Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
This is a 33.3% increase over the number of companies cited in the previous year.
The citations in the county include:
- Written MDR procedures have not been developed.
- Procedures for management review have not been established.
- Procedures for quality audits have not been established.
All of the companies cited were involved in either Devices or Food and Cosmetics sectors.
Of the companies cited, three should take voluntary actions to correct their managing operations (75%). Additionally, one company had to take regulatory and/or administrative actions (25%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Golden Lab, LLC | Food and Cosmetics | 02/21/2023 | Records - established specifications |
Golden Lab, LLC | Food and Cosmetics | 02/21/2023 | Tests, examinations - scientifically valid |
Oxygen Therapy Institute | Devices | 11/17/2023 | Lack of Written MDR Procedures |
Oxygen Therapy Institute | Devices | 11/17/2023 | Management review - Lack of or inadequate procedures |
Oxygen Therapy Institute | Devices | 11/17/2023 | Quality audits - Lack of or inadequate procedures |
Oxygen Therapy Institute | Devices | 11/17/2023 | Training - Lack of or inadequate procedures |
Oxygen Therapy Institute | Devices | 11/17/2023 | Document review, approval documentation |
Oxygen Therapy Institute | Devices | 11/17/2023 | Purchasing controls, Lack of or inadequate procedures |
Oxygen Therapy Institute | Devices | 11/17/2023 | Process control procedures, Lack of or inadequate procedures |
Oxygen Therapy Institute | Devices | 11/17/2023 | Lack of or inadequate procedures - Acceptance activities |
Oxygen Therapy Institute | Devices | 11/17/2023 | Nonconforming product, Lack of or inadequate procedures |
Oxygen Therapy Institute | Devices | 11/17/2023 | Lack of or inadequate procedures |
Oxygen Therapy Institute | Devices | 11/17/2023 | Lack of or inadequate DHR procedures |
Oxygen Therapy Institute | Devices | 11/17/2023 | Lack of or inadequate complaint procedures |
Refine USA, LLC | Devices | 08/16/2023 | Purchasing controls, Lack of or inadequate procedures |
Sawgrass Nutra Labs, LLC | Food and Cosmetics | 09/01/2023 | Grounds - drainage areas |
Sawgrass Nutra Labs, LLC | Food and Cosmetics | 09/01/2023 | Physical plant - space; equipment, materials |
Sawgrass Nutra Labs, LLC | Food and Cosmetics | 09/01/2023 | Specifications-component purity, strength, composition |
Sawgrass Nutra Labs, LLC | Food and Cosmetics | 09/01/2023 | Component - verify identity, dietary ingredient |
Sawgrass Nutra Labs, LLC | Food and Cosmetics | 09/01/2023 | Batch record - date, each step |